Aptorum logo

Aptorum

APM | NASDAQ
Chart Builder DCF Calculator
$8.26
-$1.44 (-14.85%)
At close: Aug 05, 2026, 03:39 PM ET
-14.85%

Rating

Updated: Sep 22, 2026
19
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $5.24M
1D Range
8.26 9.70
52W Range
0.60 44.70

Valuation (TTM)

PE -5.16
PB 111.54
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG -0.03
Price Target N/A
Loading financial charts...

Profile

Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and ...

Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Dec 18, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.